SCHEMBL5265027

SCHEMBL5265027

Cc1ccc(N2CCN(CCc3[nH]n(-c4ccccc4)c(=O)c3Cl)CC2)cc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 6/20 0.47
DRD2 P14416 4/20 0.47
DRD3 P35462 3/20 0.47
SIGMAR1 Q99720 2/20 0.46
MAPT P10636 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HTR1A P08908 3/20 0.43
KCNH2 Q12809 2/20 0.43
ADRA1A P35348 2/20 0.43
ADRA2A P08913 1/20 0.43
CHRM1 P11229 1/20 0.43
DRD1 P21728 1/20 0.43
SLC6A4 P31645 1/20 0.43
OPRM1 P35372 1/20 0.43
SLC6A3 Q01959 1/20 0.43
HTR7 P34969 4/20 0.43
HTR2A P28223 2/20 0.43
HTR2C P28335 1/20 0.43
ADRA1D P25100 1/20 0.41
ADRA1B P35368 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5265876 0.94 SIGMAR1 (0.48) DRD4DRD2DRD3SIGMAR1HTR1A
SCHEMBL5270524 0.87 MEN1 (0.54) DRD4DRD2DRD3MAPTNPSR1
SCHEMBL5270523 0.86 ADRA1B (0.54) DRD3SIGMAR1MAPTNPSR1HTR1A
SCHEMBL5265038 0.84 OPRM1 (0.54) DRD4DRD2DRD3SIGMAR1HTR1A
SCHEMBL5265183 0.84 DRD4 (0.48) DRD4DRD2SIGMAR1MAPTNPSR1
SCHEMBL5263985 0.83 SIGMAR1 (0.47) SIGMAR1HTR1AKCNH2HTR7
SCHEMBL5263941 0.82 MEN1 (0.57) DRD2MAPTHTR1AADRA1ADRD1
SCHEMBL5268778 0.80 MEN1 (0.48) DRD4DRD2SIGMAR1HTR1AKCNH2
SCHEMBL5266680 0.80 SLC6A2 (0.47) DRD4DRD2DRD3SIGMAR1HTR1A
SCHEMBL5268003 0.80 SIGMAR1 (0.53) SIGMAR1HTR1AKCNH2HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833800-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS AstraZeneca AB (SE) 2007-09-19 EP disclosed
WO-2006071730-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS ASTRAZENECA AB (SE) 2006-07-06 WO disclosed